The main genetic predisposition to type 1 diabetes (T1D) is known to be conferred by the HLA-DRB1, -DQA1 and -DQB1 genes in the major histocompatibility complex (MHC). Other genetic factors within this complex are known to contribute, but their identity has often been controversial. This picture is shared with several other autoimmune diseases (AIDs). Moreover, as common genetic factors are known to exist between AIDs, associations reported with other AIDs may also be involved in T1D. In this study, we have used these observations in a candidate gene approach to look for additional MHC risk factors in T1D. Using complementary conditional methods (involving conditional logistic regression and family-based haplotype tests) and analyses of linkage disequilibrium (LD) patterns, we confirmed association for alleles of the HLA-A and HLA-B genes and found preliminary evidence for a novel association of a single-nucleotide polymorphism (rs2259571) in the AIF1 gene, independent of the DRB1-DQA1-DQB1 genes and of each other. However, no evidence of independent associations for a number of previously suggested candidate polymorphisms was detected. Our results illustrate the importance of a comprehensive adjustment for LD effects when performing association studies in this complex.
Introduction
Type 1 diabetes (T1D) is an autoimmune disease (AID) characterized by the destruction of insulin-producing b-cells of the pancreas, causing irreversible insulin deficiency and a number of serious clinical complications. The most important susceptibility factors reside within the major histocompatibility complex (MHC) where particular human leukocyte antigen (HLA) class II DRB1-DQA1-DQB1 haplotypes confer high disease risk. 1, 2 However, numerous studies have strongly implicated additional T1D risk loci within the MHC. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] This complex contains an unusually high density of genes involved in immunological responses, 13 of which many are good candidates for involvement in autoimmune processes. The observation of multiple susceptibility loci in the MHC is shared with a number of other AIDs, including ankylosing spondylitis, celiac disease, Graves' disease, juvenile idiopathic arthritis, multiple sclerosis, rheumatoid arthritis, sarcoidosis, systemic lupus erythematosus and ulcerative colitis (cf. Supplementary Table 1 ). This commonality between AIDs is also reflected in genome-wide linkage scans 14 and/or association studies revealing shared genetic factors elsewhere in the genome, most notably variants of the CTLA4 and PTPN22 genes. 15 This has led to the belief that, despite a wide variety of clinical manifestations, AIDs share certain biological features that are common to the autoimmune process. Genetic mapping of the MHC in a particular AID, such as T1D, therefore represents potential value not only for the disease under study, but also for mapping of this region in other AIDs. However, association studies in the MHC are subject to severe confounding due to strong, variable and extensive linkage disequilibrium (LD), which has substantially complicated such efforts. Consequently, other than in cases of strong primary associations (frequently for antigen-presenting HLA class II molecules, such as in T1D), evidence for disease associations has often been conflicting. In an effort to resolve some of these conflicts, we used a candidate gene approach, examining previously suggested susceptibility loci from various AIDs, to identify additional risk variants for T1D within the MHC.
Results
Polymorphisms were selected on the basis of earlier reports of involvement in T1D and/or other AIDs, either directly (association reported for the marker) or indirectly (association or functional evidence reported for the gene in which the marker is located). In an effort to break up the strong LD pattern, we also included additional polymorphisms to maximize the number of haplotypes picked up by the sum of markers, based on the work of, among others, Allcock et al. (2004) . 16 Supplementary Table 1 summarizes the most important earlier references (reviews where appropriate), with direct affirmative evidence reported for the polymorphisms investigated here (Supplementary Table 2 ), and at least some form of adjustment for LD effects with known associated variants of other MHC loci.
Association tests
Unconditional transmission-disequilibrium tests of all markers showed the lowest P-value for the DRB1-DQA1-DQB1 haplotypes (P ¼ 5.8 Â 10 À101 ), as expected, and significant P-values (at a ¼ 0.05) for 39 of the 53 investigated markers (Figure 1a and Supplementary  Table 2 ). Twenty seven of these were still significant after Bonferroni correction for multiple markers (Po9.4 Â 10
À4
). However, after adjusting for effects of LD with the known class II risk variants (using singlepoint main effects tests adjusted for DRB1-DQA1-DQB1 genotypes), only five markers remained with significant results (Po0.05), that is, HLA-A, HLA-B and the singlenucleotide polymorphisms (SNPs) rs1800750 (tumor necrosis factor (TNF) À376), rs3132451 and rs2259571 (in the allograft inflammatory factor 1 (AIF1) gene), respectively ( Figure 1b and Table 1; cf. Supplementary  Table 2 for further details).
Tests of independence between significant markers
To test whether these five T1D-associated genetic variants were independent of LD also with each other, we repeated the main effects tests, still adjusting for DRB1-DQA1-DQB1 genotypes, but with the additional inclusion of each of the other significant markers in the model, one at a time ( Table 1) . None of the markers remained significant across all tests, although HLA-B only had one insignificant, but borderline, P-value. Note, however, that the number of pseudo-cases/controls varies between the tests due to slight differences in genotyping success rates and inclusion of more markers in the model, and that some of the variation in significance therefore may be attributed to variable loss of statistical power. Nonetheless, all markers appeared to influence the results of some of the other markers to some extent. The greatest impact appeared to be conferred by HLA-B, which reduced the P-values of both HLA-A and the TNF SNP rs1800750 to nonsignificant levels, but HLA-A also appeared to have some effect on HLA-B. Also, the associations of the AIF1 SNPs rs3132451 and rs2259571 appeared connected, but were seemingly unaffected by HLA-A or -B.
Analyses of alleles, haplotypes and LD patterns Reduction in statistical power is inherent in any conditional approach, especially when considering more than one conditional locus. Therefore, the employment of complementary conditional approaches, which may restrain power in a different way, is important to validate results. Moreover, as noted by Thomson et al. (2008) , no single statistical package has yet been developed that is capable of handling the complexity of MHC associations. In this situation, visual inspection and treatment of data is necessary to reveal the underlying genetic causes of an association. 17 In this study, we mapped the allelic distribution of each of the significant markers from the first regression step (Figure 1b) on each DRB1-DQA1-DQB1 haplotype and tested whether these distributions deviated significantly from that expected by LD alone. In addition to providing information on risk directions and the particular alleles involved, this approach provides valuable information about haplotype patterns, which may reveal LD dependencies not only with particular DRB1-DQA1-DQB1 haplotypes, but also between alleles at these loci. However, it should be noted that resulting associations in these tests may be haplotype specific, and not necessarily descriptive of the true effect size of tested markers. In light of the limited power and to evaluate also nonsignificant trends, markers with frequency deviations between transmitted and nontransmitted haplotypes (Po0.10) from analyses of one marker at a time conditioned on the different DRB1-DQA1-DQB1 haplotypes are given in Table 2 . In general, the HLA alleles A*24 and B*39 were significantly (Po0.05) increased, whereas A*01 and A*31 were significantly reduced among transmitted haplotypes. In addition, the HLA-B allele B*18 showed a marginally significant predisposing effect on the DRB1*03-DQA1*0501-DQB1*0201 haplotype. For the SNPs, only rs2259571 (AIF1) yielded significant results in these stratified analyses, with the minor allele C appearing to be protective. When also looking at nonsignificant tendencies (0.054Po0.10), rs1800750*A (TNF) and rs3132451*G (AIF1) (minor alleles) appeared predisposing. However, both of the DRB1-DQA1-DQB1 haplotypes where rs3132451 showed frequency deviations (that is, DRB1*04XX-DQA1*0301-DQB1*0302 and DRB1*XX-DQA1*0501-DQB1*0301) are internally heterogeneous (possibly with differential risk conferred by various DRB1*04XX or DRB1*XX alleles), which may have caused an artificial association in the regression analyses. This, and the small numbers of informative transmissions (Table 2) , questions the status of this SNP as an important risk factor in T1D.
To explore the association dependencies suggested by the regression results, we performed analyses of the implicated two-marker combinations (HLA-B with HLA-A or rs1800750, and rs2259571 with rs3132451; see above) by mapping them together on the DRB1-DQA1-DQB1 haplotypes (combined mapping). As a further guide, we examined overall LD patterns, ascertaining that dependencies between allelic associations were best captured by looking at either transmitted or nontransmitted haplotypes, depending on the risk direction (predisposing or protective, respectively). These patterns, including all markers or alleles reported in Table 2 , are given in . In line with this, combined mapping of A*24 and B*39 showed that these alleles were often transmitted together on the DRB1*08-DQA1*0401-DQB1*0402 haplotype (15 transmissions of A*24-B*39 vs 8 transmissions of other haplotypes with either allele). B*39 seemed slightly better at explaining the association on this haplotype, as the association was somewhat stronger, although numbers were too small to make a clear distinction (data not shown). Nonetheless, A*24 also showed significant associations on other DRB1-DQA1-DQB1 haplotypes (Table 2) , which almost Table 1 Regression modelling of associated markers to reveal associations independent of each other in Norwegian families
Test marker
Markers adjusted for (included in model) DRDQ DRDQ and HLA-A DRDQ and HLA-B DRDQ and rs1800750 DRDQ and rs3132451 DRDQ and rs2259571
n P-value n P -value n P -value n P -value n P -value n P -value Tests were adjusted for DRB1-DQA1-DQB1 (DRDQ) genotypes and additionally for genotypes of other markers with significant independent effects (Po0.05) of DRDQ (cf. Figure 1b) . n: number of pseudo-cases and -controls. P-values are for a likelihood ratio test (uncorrected). Degrees of freedom were 1 for tests of SNPs, 23 for HLA-B, 14 for HLA-A adjusted for DRDQ genotypes and 13 for HLA-A adjusted for DRDQ genotypes and additional markers.
never carried B*39 (only one transmission of A*24-B*39 on DRB1*1302-DQA1*0102-DQB1*0604). Therefore, at least some of the association with A*24 appeared independent of B*39. In contrast to A*24 and B*39, but still in line with the LD plots, combined mapping of the predisposing alleles A*24 and B*18 did not suggest any dependency, as only four transmitted haplotypes carrying both alleles were observed across all DRB1-DQA1-DQB1 haplotypes (n ¼ 3 on the DRB1*03-DQA1*0501-DQB1*0201 haplotype, where both showed association; Table 2 ). As all of the implicated HLA-B alleles showed predisposing tendencies, these were unlikely to be responsible for the association of the (largely) protective A*01 allele. Also, none of the HLA-B alleles were implicated on the DRB1-DQA1-DQB1 haplotypes, where A*02, A*03 or A*31 showed transmission distortions, and vice versa for B*40 (Table 2) . Overall, therefore, with a few exceptions, the associations of HLA-A and -B appeared to be largely independent.
Association dependencies between SNPs and HLA loci The predisposing rs1800750*A allele (TNF), which is rare (frequency in founders: 0.017; Supplementary Table 2 Moreover, combined mapping revealed that on the DRB1*03-DQA1*0501-DQB1*0201 haplotype, rs1800750*A was found exclusively together with B*18, whereas B*18 also had one transmission (and no nontransmissions) with rs1800750*G. Although these numbers were too small to make a distinction, this indicated that the association with rs1800750*A could be explained by LD with B*18 and not the other way around, which was supported by the overall results of the conditional regression analyses (Table 1) .
Neither the conditional regression results nor the LD patterns suggested dependence between the associations of rs2259571 (AIF1) and HLA-A or -B (Table 1 and (Table 1) . However, the individual associations all mapped to different DRB1-DQA1-DQB1 haplotypes (Table 2) , and therefore these associations nonetheless appeared to be independent.
To summarize, the association with rs1800750 (TNF) appeared to be secondary to LD with B*18, whereas the association with rs3132451 (AIF1) appeared independent, but instead may have represented an artifact. Conversely, HLA-A, HLA-B and rs2259571 (AIF1) seemed to represent largely independent associations, with particularly strong evidence for the A*01 and B*39 alleles.
Replication in T1DGC MHC data set
The three SNPs rs1800750, rs3132451 and rs2259571 were additionally investigated in an independent data set provided by the T1D Genetics Consortium (T1DGC), consisting of genotype data from 2321 multiplex T1D families. Investigations of HLA-A and -B in this data set have been described earlier. 18 The main effects tests adjusted for DRB1-DQA1-DQB1 genotypes left only the TNF SNP rs1800750 with a significant result (P exact ¼ 9.0 Â 10
À4
; Table 3 ). However, this SNP was not in Hardy-Weinberg equilibrium in the T1DGC data set (P exact ¼ 3.0 Â 10 À6 for unrelated patients), which questions the validity of this result. Moreover, haplotypebased analyses of rs1800750 with or without HLA-B conditioned on the DRB1-DQA1-DQB1 haplotypes showed similar patterns to those observed in the Norwegian families, with the only significant association on the DRB1*03-DQA1*0501-DQB1*0201 haplotype (Table 4 ) and apparent dependency on the HLA-B associations on this haplotype (B*18 in particular; data not shown). Haplotype-based analyses of the two other SNPs showed that rs2259571, but not rs3132451 (data not shown), was significantly associated on the same DRB1-DQA1-DQB1 haplotypes as in the Norwegian families (Tables 4 and 2 ). 
Discussion
In this study, we confirmed T1D associations independent of the DRB1-DQA1-DQB1 genes for alleles of the HLA-A and HLA-B genes in the MHC class I region and found novel evidence for DRB1-DQA1-DQB1-independent T1D association for three SNPs (rs1800750, rs3132451 and rs2259571) in the TNF cluster of the MHC class III region. In addition, we demonstrated that, with the exception of rs1800750, all of these associations showed independence also of each other.
Confirmation of MHC class I associations
A DRB1-DQA1-DQB1-independent association between T1D and certain HLA-B alleles has been demonstrated in several reports, [3] [4] [5] [6] 10, 18 but most convincingly by a British combined case-control/family study 3 and in a large family material provided by the T1DGC. 18 In both earlier studies and this study, the most consistent evidence was observed for the B*39 and B*18 alleles, with demonstrated independence of a high number of neighboring markers. The combined evidence for HLA-B strongly suggests that this is a primary risk locus in T1D, implying that future T1D studies in the MHC should adjust for LD effects from alleles of this locus in addition to the DRB1-DQA1-DQB1 loci.
DRB1-DQA1-DQB1-independent association between HLA-A and T1D has also been reported earlier, 3, 19, 20 most convincingly in the above-mentioned British study, although an independent association could only be demonstrated in the case-control materials, and not in families. 3 The alleles showing individual significant associations in our study (A*01, A*24 and A*31) also match with this last report, and partly (A*01 and/or A*24) with earlier reports. 19, 20 Hence, the present results show that the DRB1-DQA1-DQB1-independent T1D association to alleles at the HLA-A locus is consistent across different populations and provides further evidence for an association also in families. Importantly, our results provide confirmatory evidence that the HLA-A associations are largely independent of HLA-B. Even so, recent studies have indicated that the HLA-A associations may be secondary to LD with another, yet unconfirmed, locus telomeric of this gene, 4, 18 which cannot be excluded with our results.
Alleles of the HLA-A and -B loci have been associated, independently of the DRB1-DQA1-DQB1 genes, with accelerated b-cell destruction and progression to clinical disease in T1D patients (most notably, A*24), [21] [22] [23] [24] as well as with variable age of onset. 3, 6, [25] [26] [27] Although our study did not allow for appropriate testing of these effects (see Materials and methods), most of the alleles associated with disease status in our study and those of others overlap with those identified with relevance for these specific aspects (that is, A*24, B*18 and B*39 associated both with disease status, accelerated progression and/or younger age of onset, whereas reversed associations have been reported for A*01). Moreover, a direct role for class I genes has been demonstrated in CD8 þ T-cell mediated destruction of b-cells in the nonobese diabetic mouse model of T1D. [28] [29] [30] [31] [32] [33] These reports indicate that HLA-A and/or -B, or other loci in high LD with the associated alleles, may be particularly important in the processes between initiation of autoimmunity and progression to overt disease. Furthermore, HLA class II-independent associations with HLA-A and -B have also been reported with other AIDs. In particular, HLA-A has been implicated in multiple sclerosis [34] [35] [36] and juvenile idiopathic arthritis, 37, 38 whereas HLA-B is a well-known risk factor in ankylosing spondylitis 39 and has been implicated in systemic lupus erythematosus. 40 This raises the possibility that these genes represent susceptibility loci that are involved in common, autoimmune processes.
Novel AIF1 association In addition to confirm earlier reports for HLA-A and -B, we found preliminary, novel evidence for risk effects both independently of DRB1-DQA1-DQB1, HLA-A and -B, for rs2259571 in the 5 0 -untranslated region/intron 3 (depending on isoform) of the AIF1 gene. The AIF1 protein is involved in inflammatory responses, allograft rejection and macrophage regulation, 41 and has been implicated in T1D by functional studies, showing regulatory effects on insulin secretion in mice and accumulation in the pancreas of prediabetic Bio-Breeding (BB) rats. 42 Also, a number of studies have implicated this protein in other AIDs, 41 including a recent report showing that AIF1 may be crucial in the pathogenesis of rheumatoid arthritis. 43 In addition to rs2259571, we observed an independent association of rs3132451 in the promoter of the same gene, but this result was most likely an artifact, both judging from the heterogeneity within each of the two individual DRB1-DQA1-DQB1 haplotypes the associations mapped to and the negative result in the T1DGC families. The replication attempt in the T1DGC data set was also negative for rs2259571 for the regression analyses, raising the possibility of a type I error. However, when mapping the allele distribution on the different DRB1-DQA1-DQB1 haplotypes in the T1DGC families, rs2259571 showed significant associations on the same haplotypes as in the Norwegian families. Therefore, this SNP could still mark the same effect in both data sets, although the SNP itself is not Only significant results (Po0.05) for DRB1-DQA1-DQB1 haplotypes implicated in the Norwegian families (cf. Table 2 ) are shown. Cf. Table 2 for definitions.
most likely to be a primary locus. A possible explanation for the lack of association in the regression analyses could be that the underlying LD pattern with the primary locus was population specific, and therefore could be weaker in a relatively heterogeneous material, such as the T1DGC families, which, although mostly Caucasoid, contains samples from all over Europe, North America and Australia. However, this question can only be answered by replication studies and further finemapping in other, preferably homogenous populations.
Associations limited to a subset of DRB1-DQA1-DQB1 haplotypes None of the associated alleles of HLA-A, HLA-B or the AIF1 SNP rs2259571 showed signs of frequency deviations across all DRB1-DQA1-DQB1 haplotypes, which could indicate specific epistatic effects with the class II loci. However, other possible explanations include limited power resulting from stratification according to DRB1-DQA1-DQB1 haplotypes or, in the event that the markers do not constitute real, etiological loci, complex underlying LD patterns that make the associations visible only on certain DRB1-DQA1-DQB1 haplotypes. Answers to these questions can only be given after more definite evidence is obtained for these markers, in particular rs2259571 and HLA-A, and also for certain HLA-B alleles, and/or the real etiological loci have been identified.
No independent T1D association with other previously reported AID-associated variants
No evidence for DRB1-DQA1-DQB1-independent association was found for polymorphisms in the other candidate genes, including HLA-E, MICA, MICB, BAT1, NFKBIL1, LTA, HSPA1L/B, C2, CFB, AGER and BTNL2. This was despite the fact that a large number of these polymorphisms showed highly significant association before adjusting for LD with the DRB1-DQA1-DQB1 loci, demonstrating the necessity of a conditional approach throughout the MHC. Several of the genotyped loci, including variants in the BAT1, NFKBIL1, LTA, TNF and AIF1 genes, are located within the TNF cluster in the MHC class III region. This unusually dense cluster of genes has been implicated in predisposition for T1D and other AIDs in numerous reports (for example, Supplementary Table 1 ), with particular focus on the TNF gene itself, partly because of the demonstrated clinical benefits of TNF blockers in several AIDs. A significant DRB1-DQA1-DQB1-independent association was indeed observed for rs1800750 (also known as TNF À376) in this gene, both in the Norwegian and the T1DGC families. However, the observed association with rs1800750 could apparently be explained by LD with the B*18 allele in both data sets. Moreover, none of the other polymorphisms earlier reported to be independently associated, most notably rs1800629 (TNF -308), showed evidence of independent association in our study. This is in agreement with a recent report, showing that apparent association of rs909253 (LTA NcoI RFLP), rs1800629 (TNF À308) and rs361525 (TNF À238), all of which were also investigated in this study, could be explained by LD with either DRB1-DQB1 haplotypes or the B*18 allele. 44 These observations further illustrate our earlier point of adjusting also for HLA-B for T1D association studies in the MHC.
Similar to T1D, many AIDs show indications of multiple susceptibility loci within the MHC, and thus share many of the challenges in efforts to fine-map this region. Each of these loci are most likely to act as confounding factors, illustrated by the growing body of evidence for T1D associations attributable to LD with HLA-B alleles, in addition to the known primary susceptibility loci DRB1-DQA1-DQB1. Moreover, definitions of risk alleles at identified primary loci may vary (for example, controversies about the 'shared epitope' hypothesis in rheumatoid arthritis 45 ), possibly leading to insufficient adjustment for confounding factors even if conditional approaches are used. Hence, conflicting association reports in this region are not surprising. Our approach to these problems has been to select candidate polymorphisms on the basis of reports with at least some form of adjustment for known MHC risk loci. This strategy allowed us to examine the results of these reports with respect to each other and increased the a priori likelihood (and thus reduced the expected type I error rate) compared with a hypothesis-free screening approach. Moreover, our strategy employed two complementary conditional approaches, increasing the validity of our results. Both of these considered all DRB1-DQA1-DQB1 haplotype variants, which is justified by the observed risk-continuum from predisposing to protective haplotypes of these loci in T1D.
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Conclusion
In conclusion, our findings support the association between alleles at the HLA-B locus (in particular, B*18 and B*39) and T1D and provides further evidence for an independent association with HLA-A alleles (in particular, A*01, A*24 and A*31), or alleles at an unidentified locus in high LD with these alleles. In addition, a novel independent association of rs2259571 in intron 3/5 0 -untranslated region of the AIF1 gene was observed, warranting follow-up studies in other populations.
Materials and methods
Family materials
A total of 434 Norwegian T1D families were recruited as described elsewhere 46 and patients diagnosed before the age of 15 years according to the EURODIAB criteria. 47 The inclusion only of patients with a relatively young age of onset is most likely to result in a clinically homogeneous patient population, presumably excluding atypical adult manifestations of T1D (including latent autoimmune diabetes in adults 48 ). Even though associations between MHC loci and age of onset have been suggested, 3, 6, [25] [26] [27] such analyses were not justified in this study, as our analyses already included a large number of parameters in a relatively small population, with resulting loss of statistical power. Moreover, the range of age of onset in our study was small and would therefore have allowed only for limited tests of this effect. The families mainly consisted of trios with one affected child and both parents, but 20 families had two or more siblings included, for a total of 1316 individuals. For replication studies of rs1800750, rs3132451 and rs2259571, we used data from the T1DGC MHC data set (2007.02.MHC). The editing and recoding of this data set has been described elsewhere, 18 resulting in a data set with a total of 2301 multiplex T1D families.
Genotyping
Genotyping data and pedigree information were handled using Progeny Lab v6 (Progeny Software LLC, South Bend, IN, USA). Genotyping was performed on whole genome-amplified DNA (GenomiPhi DNA Amplification Kit, GE Healthcare, Piscataway, MD, USA). A total of 58 SNPs were genotyped using SNPlex (Applied Biosystems, Foster City, CA, USA), TaqMan (Applied Biosystems) or MassARRAY technology (Sequenom, San Diego, CA, USA), and four insertionsdeletions (indels) using fragment length analysis with fluorescence-labelled, tailed primer pairs on an ABI3730 automated sequencer (Applied Biosystems). Genotyping with SNPlex and MassARRAY technology was performed at CIGENE (Å s, Norway). Detailed reaction setup and primer sequences are available in Supplementary Text 1. Genotyping of HLA-A and HLA-B was performed using sequence-based typing protocols and primers amplifying exons 2 and 3, using the Platinum Taq PCRx DNA polymerase kit (Invitrogen, Carlsbad, CA, USA). Primers and detailed PCR conditions are available from the authors upon request. Sequencing was performed using BigDye Terminator v3.1 chemistry (Applied Biosystems) on an ABI3730 automated sequencer. Sequence alignment and allele assignment were performed using Assign v3.2.7 software (Conexio Genomics, Applecross, WA, Australia). In addition, some samples were genotyped using RELI SSO HLA-A and -B Typing Kits (Invitrogen) to validate results. Genotyping of HLA-DQA1, -DQB1 and -DRB1 has been performed earlier using several protocols, as described elsewhere. 46 In addition, a few remaining samples with DRB1*04 alleles at two-digit resolution were genotyped in the context of this study using sequence-based typing, as described above, to increase resolution to four digits.
DRB1-DQA1-DQB1 haplotype codes
Genotypes for HLA-DRB1, -DQA1 and -DQB1 were replaced by a haplotype code spanning all three loci, with phase inferred on the basis of common haplotypes. Mendelian consistency (verified with Pedcheck 49 ) was evaluated as a quality control. A total of 99.9% of the samples had genotypes at the HLA-DQA1 and -DQB1 loci (four-digit resolution), but only 64.7% had genotypes at the HLA-DRB1 locus (mixed resolution, 2-6 digits), and of these, 40.6% were conclusively typed for only one allele. However, due to strong LD, the remaining genotypes at this locus could be inferred from haplotypes of the two other loci (the exception was DRB1*04 subtypes, which was always determined by direct genotyping), resulting in a total 'genotyping' rate of the DRB1-DQA1-DQB1 haplotype code equal to that of the HLA-DQA1 and -DQB1 loci. The rationale behind this method has been discussed earlier. 18 Quality control and pruning Markers with genotyping call rates below 79% (n ¼ 1), bad allele clustering (n ¼ 2) or that were monomorphic (n ¼ 6) were removed from further analyses. Mendelian inheritance was verified using Pedcheck. In cases where an unusually high amount of Mendelian errors across all markers were observed within a single family (which could indicate a sample switch or erroneous family member assignment), the affected sample or (in cases where the responsible sample was ambiguous) the entire family was removed from analysis (38 samples in 15 families, 11 of these families with all members removed). Genotypes for two SNPs in the MICA gene were removed because of high Mendelian error rates in the remaining families. Remaining errors were removed for the affected polymorphism in the entire involved family. Hardy-Weinberg equilibrium was calculated in unrelated subjects using the exact test implemented in the program Pedstats. 50 One SNP showed significant deviation from expected genotype frequencies (Po0.01) and was removed. Details of the removed markers are available in Supplementary Table 2 .
The above-mentioned procedures resulted in a data set with 1278 samples in 423 families, with genotypes for 46 SNPs and 4 indels, in addition to HLA-A, HLA-B and the DRB1-DQA1-DQB1 haplotype codes.
Statistical analysis
Transmission-disequilibrium test was performed using the extended transmission-disequilibrium test implemented in UNPHASED v2.403. 51 Conditional logistic regression, adjusted for DRB1-DQA1-DQB1 genotypes, was used for evaluation of the importance of SNPs, indels and allelic variants at the HLA-A, and -B loci on T1D susceptibility. We used the conditioning strategy 4 described by Cordell and Clayton, 52 implemented in STATA (STATA Corp., College Station, TX, USA). This method involves 'main effects' tests, where comparisons are made between regression models including the effects of a primary locus and models including the effects of the primary locus and one or more additional loci. A slightly modified version of the main effects test by Cordell and Clayton, implemented in UNPHASED, was used for evaluation of the rs1800750, rs3132451 and rs2259571 SNPs in the T1DGC data set.
Global and allelic LD measures (D 0 and D 0 and r 2 , respectively) were calculated using UNPHASED with expectation-maximization estimation. Raw data plots were generated in GOLD 53 and edited using Adobe Illustrator.
Details of the haplotype-based methods have been described elsewhere. 18 Briefly, maximum-likelihood haplotype frequency estimates combining markers with DRB1-DQA1-DQB1 haplotypes were computed using FAMHAP. 54 On the basis of these estimates, tables with haplotype transmission/nontransmissions from heterozygous parents were constructed as described elsewhere, 54 and haplotypes were organized in separate groups for each DRB1-DQA1-DQB1 haplotype. Statistically significant deviations of one marker allele at a time or haplotypes of two markers (combined mapping) within each of these DRB1-DQA1-DQB1 groups were tested in 2 Â 2 contingency tables with Fisher's exact test (two-tailed; using EpiCalc 2000; http://www.brixtonhealth.com/epicalc.html) and odds ratios were calculated. For combined mapping, the resulting small numbers among individual haplotypes did not allow for conditional tests adjusting for more than the DRB1-DQA1-DQB1 loci. However, colocalization of predisposing or protective alleles at two different loci on transmitted or nontransmitted haplotypes, respectively,
